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lyzed for Candida species typing by routine methods. All
Candida albicans isolated were inoculated on CHROMagar
Candida medium, and Germ tube test and chlamydospore
production were performed. The carbohydrate assimilation
patterns of all isolates were studied using the API 32C sys-
tem. To identify the two respective species, C. albicans and
C. dubliniensis, PCR was done by speciﬁc primers. Suscep-
tibility test for isolates were performed by the agar-based
E-test method.
Results: Of 89 isolates diagnosed previously as C. albi-
cans, two isolates were C. dubliniensis with PCR test, 83.9%
were sensitive and 16.1% were resistant to amphotericin
B, 89.1% were sensitive, 4.3% susceptible-dose dependent,
and 6.6% were resistant to ﬂuconazole, 9% were sensitive,
70% susceptible-dose dependent, and 21% were resistant
to itraconazole, 91% were sensitive 4.5% susceptible-dose
dependent, and 4.5% were resistant to voriconazole, 91%
were sensitive, 9% were resistant to ketoconazole. All of C.
dubliniensis were sensitive to the ﬁve anti-fungal agents.
Conclusion: Voriconazole is the best antifungal against C.
albicans. It is the ﬁrst study of C. dubliensis from Iran.
doi:10.1016/j.ijid.2008.05.749
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Background: In neutropenic patients particularly those
undergone chemotherapy for hematologic malignancies
invasive fungal infections are the major causes of morbidity
and mortality. Candida spp. and Aspergillus spp. are respon-
sible for more than 80% of all fungal infections in these
patients. The aim of this study was to determine the preva-
lence and efﬁciency of PCR-Enzyme Link Immunosorbent
Assay method (PCR-ELISA) for detection of invasive fungal
infections in patients with hematologic malignancies.
Patients and Methods: From 2005 to 2007, 224 patients
with hematologic malignancies (that received chemother-
apy) were evaluated for invasive fungal infections in Shiraz,
southern Iran. Ethylene diamine tetra-acetic acid anticoagu-
lant whole blood samples were collected prospectively once
a week and stored at −20 ◦C until the examination. All col-
lected blood samples were assayed for the presence of the
bands on ethidium bromide stained gel, and for hybridiza-
tion.
Results: The female-to-male ratio was 71:153, mean age
of patients was 35.2 years, and mean of hospitalization
period was 23.1 days. One-hundred-nineteen patients (53%)
had Candida colonization in different sites of their bodies.
Fungal infections were diagnosed in 44 patients (19.6%).
PCR-ELISA was positive in 16 (7.1%) patients that had clin-
ical and radiological signs for invasive aspergillosis and 28
patients (12.5%) had positive PCR-ELISA results for systemic
candidiasis. The etiologic agents were C. albicans (22 cases),
A. ﬂavus (12 cases), C. tropicalis (4 cases), A. fumigatus (4
cases), and C. krusei (2 case). The sensitivity, speciﬁcity, and
positive and negative predictive values were 83.3%, 91.7%,
76.9%, and 94.3%, respectively.
Conclusion: We demonstrated in the present study
the prevalence of invasive fungal infections in leukemic
patients. PCR-ELISA method can potentially serve as a use-
ful tool for the management of patients suffering from
hematological malignancies, and at risk for systemic fungal
infections.
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Aspergillosis is a rare cause of pulmonary inﬁltrate in SLE
& carries bad prognosis with a mortality of 70—80%. Mr. MJ,
31 year old male accountant, was admitted with fever &
rash of 3 months and polyarthralgia of 2 months duration.
At the time of admission examination revealed high grade
fever, tachycardia, mild tachypnea, pallor, oral ulcerations
& candidiasis, sub conjunctival hemorrhages, erythematous
maculopapular rash over trunk & legs. Investigations showed
anemia, leucopenia, thrombocytopenia, prolonged aPTT &
strongly positive ANA. CXR was normal and IV methylpred-
nisolone was initiated with piperacillin-tazobactum. On the
2nd day, he had two episodes of seizure and became restless.
MRI brain revealed vasculitis and he was given a dose of IV
cyclophosphamide. On the 6th day he developed breathless-
ness with desaturation and CXR showed diffuse inﬁltrates.
During this period he continued to have leucopenia & throm-
bocytopenia, for which G-CSF was given and antibiotics
were changed to meropenem & teicoplanin. He developed
deep vein thrombosis of left leg and was treated with hep-
arin. CXR got worsened and bronchoscopy was done, which
revealed whitish mucous patch in left lateral wall of main
bronchus and at upper lobe oriﬁce. Sputum for fungal cul-
ture isolated aspergillus fumigatus. Bronchial brush cytology
showed acute angle branching septate fungi suggestive of
aspergillosis. Sputum for AFB and cultures were negative.
Skin biopsy was consistent with SLE & 24 hour urine pro-
tein was above 4 gm. He had low complements, high LDH,
positive coombs test, positive antiphospholipid antibodies
and prolonged Russell venom viper time. He was treated
with amphotericin B for 4 days, but he deteriorated &
succumbed. Pulmonary inﬁltrates are uncommon in SLE &
can be due to lupus pneumonitis, interstitial ﬁbrosis, alve-
olar hemorrhages and opportunistic infections. Pulmonary
aspergillosis is rarely described in SLE and most important
predisposing factor for aspergillosis is neutropenia.
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